Xiang Wang

Xiang Wang

Auto-generated profile, based on publicly available information

Xiang Wang

State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cell
Verified
Journal Article
Closed access
JXJun-Yu Xu
Jun-Yu Xu
CZChunchao Zhang
Chunchao Zhang
XWXiang Wang
Xiang Wang
LZLinhui Zhai
Linhui Zhai
YMYiming Ma
Yiming Ma
MTMinjia Tan
Minjia Tan

1 June 2019 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
XWXiang Wang
Xiang Wang
BZBotao Zhang
Botao Zhang
YYYikun Yang
Yikun Yang
JZJiawei Zhu
Jiawei Zhu
SCShujun Cheng
Shujun Cheng
TXTing Xiao
Ting Xiao
T cells and T cell receptors (TCRs) play pivotal roles in adaptive immune responses against tumors. The development of next-generation sequencing technologies has enabled the analysis of the TCRβ repertoire usage. Given the scarce investigations on the TCR repertoire in lung cancer tissues, in this study, we analyzed TCRβ repertoires in lung cancer tissues and the matched distant non-tumor lung tissues (normal lung tissues) from 15 lung cancer patients. Based on our results, the general distribution of T cell clones was similar between cancer tissues and normal lung tissues; however, the proportion of highly expanded clones was significantly higher in normal lung tissues than in cancer tissues (0.021% ± 0.002% vs. 0.016% ± 0.001%, P = 0.0054, Wilcoxon signed rank test). In addition, a significantly higher TCR diversity was observed in cancer tissues than in normal lung tissues (431.37 ± 305.96 vs. 166.20 ± 101.58, P = 0.0075, Mann-Whitney U test). Moreover, younger patients had a significantly higher TCR diversity than older patients (640.7 ± 295.3 vs. 291.8 ± 233.6, P = 0.036, Mann-Whitney U test), and the higher TCR diversity in tumors was significantly associated with worse cancer outcomes. Thus, we provided a comprehensive comparison of the TCR repertoires between cancer tissues and matched normal lung tissues and demonstrated the presence of distinct T cell immune microenvironments in lung cancer patients.

31 March 2023
Verified
Other
Open access
XRXinxin Ren
Xinxin Ren
ZRZhuoxian Rong
Zhuoxian Rong
XLXiaoyu Liu
Xiaoyu Liu
JGJie Gao
Jie Gao
XXXu Xu
Xu Xu
YDYuezhen Deng
Yuezhen Deng
Supplemental Table 7 Correlation between the mRNA level of MTHFD2 and the clinical features of HCC.

31 March 2023
Verified
Other
Open access
XRXinxin Ren
Xinxin Ren
ZRZhuoxian Rong
Zhuoxian Rong
XLXiaoyu Liu
Xiaoyu Liu
JGJie Gao
Jie Gao
XXXu Xu
Xu Xu
YDYuezhen Deng
Yuezhen Deng
Supplemental Table 7 Correlation between the mRNA level of MTHFD2 and the clinical features of HCC.